| SDG 3 - Keywords | ||||
| 2009 pandemic | cancer invasion | diffuse large b-cell lymphoma (dlbcl) | kaposi's sarcoma-associated herpesvirus | persistent asthma |
| a (h1n1) | cancer liver | disease, diabetes | kidney cancer | plasmodium falciparum malaria |
| a suicide attempt | cancer lung | dominant polycystic kidney disease | kidney disease patients | pneumocystis carinii pneumonia |
| access to health services | cancer management | drug addiction | kidney diseases | polycystic kidney disease (adpkd) |
| access to healthcare | cancer meta-analysis | drug dependence | klebsiella pneumonia | postmenopausal breast |
| acquired immunodeficiency syndrome (aids) | cancer metastases | drug-resistant tuberculosis | large b cell | postmenopausal breast cancer |
| acquired pneumonia | cancer models | duct carcinoma | large b cell lymphoma | postpartum hemorrhage |
| active tb | cancer network | ductal carcinoma in situ (dcis) | large cell lymphoma | prevalence of asthma |
| active tuberculosis | cancer outcomes | e antigen | laryngeal cancer | prevalence of hiv |
| acute asthma | cancer pain relief | e virus | laryngeal carcinoma | prevalence of overweight and obesity |
| acute ischaemic stroke | cancer pain | early cancer | latent tuberculosis | prevalence of type 2 diabetes |
| acute ischemic stroke | cancer pathogenesis | early detection of cancer | latent tuberculosis infection | prevention of stroke |
| acute lymphocytic leukemia | cancer patients' | early gastric cancer | lead exposure | primary cancer |
| acute myelogenous leukemia | cancer predisposition | early stage breast cancer | lead poisoning | primary cancers |
| acute myelogenous leukemia (aml) | cancer prevention | early-stage breast cancer | leprosy patients | primary hiv |
| acute myeloid leukemia | cancer prognostic | ebola virus | leprosy | primary liver cancer |
| acute promyelocytic leukemia (apl) | cancer proliferation | embryonal carcinoma | leukemia cell line | primary lung cancer |
| acute pulmonary embolism | cancer prostate | emergency contraception | leukemia cell lines | primary melanoma |
| acute stroke patients | cancer quality of life | endometrial cancers | leukemia inhibitory | progression of cancer |
| adenoid cystic carcinoma | cancer radiation | endometrial carcinoma | leukemia inhibitory factor | prostate cancer (pc) |
| adolescents with type 1 diabetes | cancer radiotherapy | end-stage kidney disease | leukemia inhibitory factor (lif) | prostate cancer cell line |
| adrenocortical carcinoma | cancer rates | environment and human health | leukemia/lymphoma | prostate cancer cell lines |
| adult cancer | cancer registries | epidermoid carcinoma | lewis lung | prostate cancer progression |
| adults with diabetes | cancer related | epithelial cancer | lewis lung carcinoma | prostate cancer radical |
| adults with type 2 diabetes | cancer resection | epithelial cancers | liver cancer cells | prostate cancer radical prostatectomy |
| advanced cancer patients | cancer resistance | epithelial ovarian cancer (eoc) | living with hiv/aids | prostate cancer risk |
| advanced cervical cancer | cancer risk factors | esophageal squamous cell carcinoma (escc) | lobular carcinoma | prostate cancer screening |
| advanced colorectal cancer | cancer risks | european organization for research and treatment of cancer | locally advanced breast cancer | prostate cancer treatment |
| advanced hcc | cancer screening program | ewing sarcoma | locally advanced rectal cancer | prostatic cancer |
| advanced hepatocellular | cancer sites | ewing's sarcoma | lung cancer cell line | prostatic carcinoma |
| advanced hepatocellular carcinoma | cancer specific | experimental diabetes | lung cancer cell lines | pulmonary hypertension (ph) |
| advanced lung cancer | cancer staging | expression in cancer | lung cancer risk | pulmonary tb |
| advanced melanoma | cancer stem cells (cscs) | family history of breast cancer | lung cancer screening | rabies virus |
| advanced non-small cell lung cancer (nsclc) | cancer stem cells | family history of diabetes | lung carcinoma cells | rectal cancers |
| advanced non-small-cell lung cancer | cancer study | female breast cancer | lymphoblastic leukemia | rectal carcinoma |
| advanced ovarian | cancer subtypes | fetal death | lymphoma (hl) | recurrent miscarriage |
| advanced ovarian cancer | cancer surveillance | following stroke | lymphoma cell | recurrent pregnancy |
| advanced pancreatic cancer | cancer survivor | fulminant hepatitis | lymphoma patients | recurrent pregnancy loss |
| advanced prostate cancer | cancer survivorship | functional assessment of cancer therapy | macrovascular complications | recurrent stroke |
| advanced rectal cancer | cancer syndrome | gallbladder cancer | malaria cases | rehabilitation stroke |
| affordable care act | cancer therapeutic | gallbladder carcinoma | malaria control | renal carcinoma |
| after cancer | cancer therapeutics | gastric cancer cell line | malaria infection | renal cell cancer |
| aids epidemic | cancer type | gastric cancer cell lines | malaria parasites | reproductive health |
| aids-related | cancer vaccine | gastric cancers | malaria vaccine | reproductive healthcare |
| alcohol abuse | cancer vaccines | gastrointestinal cancer | malaria vector | respiratory diseases |
| alcohol misuse | cancer xenograft | gastrointestinal cancers | malt lymphoma | retinoblastoma (rb) |
| alcohol problems | cancer xenografts | gynecologic cancer | mammary cancer | retinoblastoma protein |
| alcohol use disorder | cancer-free | gynecological cancer | mammary carcinoma | rheumatic heart |
| alcohol-related problems | cancer-related death | h1n1 influenza | management of asthma | rheumatic heart disease |
| all cancer | cancer-related deaths | h37rv | management of cancer | risk of asthma |
| all cancers | cancer-related genes | h3n2 | management of diabetes | risk of cardiovascular diseases |
| allergy asthma | cancer-related mortality | haart | mantle cell lymphoma | risk of colorectal cancer |
| allergy, asthma | cancer-specific mortality | haemophilus influenzae type | mantle cell lymphoma (mcl) | risk of coronary heart disease |
| american joint committee | carcinoma cases | haemophilus influenzae type b | marburg | risk of diabetes |
| american joint committee on cancer | carcinoma in situ (dcis) | hcc cell lines | maternal complications | risk of hiv |
| anal cancer | carcinoma liver | hcv treatment | maternal death | risk of ischemic stroke |
| anaplastic large | carcinoma metastasis | head and neck cancer patients | maternal deaths | risk of lung cancer |
| anaplastic large cell | carcinoma of the bladder | head and neck cancer | maternal morbidity | risk of obesity |
| anaplastic large cell lymphoma | carcinoma of the breast | head and neck cancers | maternal obesity | risk of stroke |
| anaplastic lymphoma | carcinoma of the cervix | head and neck squamous cell carcinoma (hnscc) | maternity care | risk of suicide |
| anaplastic lymphoma kinase | carcinoma of the head and neck | health and the environment | mcf-7 breast cancer | risk of type 2 diabetes |
| anaplastic lymphoma kinase (alk) | carcinoma of the lung | health care access | mcf-7 breast cancer cells | rotavirus infection |
| and colon cancer | carcinoma prognosis | heart attack | mdr-tb | rotavirus vaccine |
| and cystic fibrosis | carcinoma tissue | heart disease risk | measles virus | s aureus (mrsa) |
| and endometrial cancer | cardiovascular diseases (cvd | heavy drinking | medullary thyroid carcinoma | sarcoma-associated herpesvirus |
| and heart disease | cardiovascular diseases (cvd) | hemorrhagic stroke | melanoma cell line | sars-cov |
| and human immunodeficiency virus | carotid artery disease | hepatitis (aih) | melanoma cell lines | seasonal influenza |
| and lymphoma | castration-resistant prostate | hepatitis a virus | melanoma metastasis | serous carcinoma |
| and pulmonary hypertension | castration-resistant prostate cancer | hepatitis a virus (hav) | mellitus type 2 | severe acute respiratory syndrome |
| and squamous cell carcinoma | causes of cancer | hepatitis b and c | merkel cell carcinoma | severe acute respiratory syndrome (sars) |
| and substance use disorders | ccrcc | hepatitis b e antigen | mers | severe malaria |
| anticancer activities | cd4 cell counts | hepatitis b infection | metastatic breast cancer (mbc) | severe obesity |
| anti-cancer activity | cell carcinoma cells | hepatitis b patients | metastatic breast cancer | severe pneumonia |
| anticancer activity | cell lung cancer cells | hepatitis b surface antigen (hbsag) | metastatic carcinoma | severe pulmonary hypertension |
| anti-cancer agent | cell sarcoma | hepatitis b vaccination | metastatic castration-resistant | sex education |
| anti-cancer agents | central nervous system lymphoma | hepatitis b vaccine | metastatic castration-resistant prostate | sexual and reproductive health |
| anti-cancer drug | cerebral malaria | hepatitis b | metastatic castration-resistant prostate cancer | shiga toxin-producing escherichia coli |
| anti-cancer drugs | cerebrovascular disease | hepatitis c infection | metastatic colorectal cancer (mcrc) | skin cancer |
| anticancer effect | cervical cancer cell | hepatitis c patients | metastatic prostate cancer | small cell carcinoma |
| anti-cancer effects | cervical cancer cells | hepatitis e | metastatic renal cell carcinoma | small cell lung cancer (sclc) |
| anticancer efficacy | cervical cancer patients | hepatitis e virus | methicillin-resistant s aureus (mrsa) | small-cell lung |
| anticancer properties | cervical cancers | hepatitis e virus (hev) | midwife | small-cell lung cancer |
| anticancer therapies | cervical carcinoma | hepatitis virus | midwives | smallpox |
| anti-cancer therapy | cervix cancer | hepatocellular carcinoma cell | miscarriage | solid cancers |
| anticancer treatment | childhood acute lymphoblastic leukemia | hepatocellular carcinoma cells | most common cancers | spread of hiv |
| anti-hepatitis | childhood asthma | hereditary breast | mouse melanoma | squamous cell cancer |
| anti-hiv activity | childhood leukemia | hereditary cancer | mrsa infection | squamous cell carcinoma (escc) |
| anti-hiv-1 | children with cancer | hereditary nonpolyposis | mrsa strains | squamous cell carcinoma of the head |
| anti-influenza | children with type 1 diabetes | highly pathogenic avian influenza | mrsa | squamous cell carcinoma of the head and |
| antimalarial activity | chronic asthma | history of asthma | mucoepidermoid carcinoma | squamous cell carcinoma of the head and neck |
| antimalarial drug | chronic hepatitis b (chb) | history of breast cancer | multidrug-resistant tuberculosis | stable coronary artery disease |
| antimalarial drugs | chronic hepatitis b patients | history of cancer | multiple cancer | stillbirths |
| anti-obesity | chronic hepatitis b virus | history of stroke | multiple cancers | stomach cancer |
| antiretroviral therapy (cart) | chronic hepatitis b virus (hbv) | hiv- | murine melanoma | streptozotocin-induced diabetes |
| anti-tb | chronic hepatitis c (chc) | hiv and aids | muscle-invasive | stroke association |
| antituberculosis | chronic hepatitis c patients | hiv diagnosis | mycobacterium tuberculosis (mtb) | stroke care |
| anti-tuberculosis | chronic hepatitis c virus (hcv) | hiv epidemic | mycobacterium tuberculosis complex | stroke incidence |
| apoptosis in cancer cells | chronic hepatitis c virus (hcv) infection | hiv incidence | mycobacterium tuberculosis infection | stroke onset |
| arsenic exposure | chronic hepatitis c virus infection | hiv infected patients | mycobacterium tuberculosis | stroke outcome |
| aspiration pneumonia | chronic hepatitis c | hiv negative | myeloid leukemia cells | stroke rate |
| asthma & | chronic kidney disease patients | hiv protease | myeloid leukemia | stroke rehabilitation |
| asthma and chronic obstructive pulmonary disease | chronic myelogenous leukemia (cml) | hiv replication | myelomonocytic leukemia | stroke severity |
| asthma and copd | chronic obstructive lung disease | hiv rna | nasopharyngeal cancer | stroke therapy |
| asthma children | chronic stroke | hiv test | national comprehensive cancer network | stroke treatment |
| asthma exacerbation | chronic thromboembolic | hiv transmission | national institutes of health stroke scale | stroke unit |
| asthma exacerbations | chronic thromboembolic pulmonary | hiv treatment | national institutes of health stroke scale (nihss) | stroke volume (sv) |
| asthma in children | chronic thromboembolic pulmonary hypertension | hiv type 1 | neck cancers | stroke; |
| asthma management | chronic viral hepatitis | hiv vaccine | negative breast cancer | structural heart disease |
| asthma severity | cirrhosis and hepatocellular carcinoma | hiv viral load | neonatal care | substance abuse |
| asthma symptoms | clear cell carcinoma | hiv/aids patients | neonatal complications | substance dependence |
| asthma treatment | clear cell renal | hiv/hcv | neonatal death | substance use disorders |
| attempted suicide | clear cell renal cell | hiv-1 envelope | neonatal deaths | sudden infant |
| autoimmune diabetes | clear cell renal cell carcinoma | hiv-1 in | neonatal morbidity | sudden infant death |
| autosomal dominant polycystic | clinical cancer | hiv-1 infected | nervous system lymphoma | sudden infant death syndrome |
| autosomal dominant polycystic kidney | clinically localized | hiv-1 protease | neuroblastoma cell | sudden infant death syndrome (sids) |
| autosomal dominant polycystic kidney disease | clinically localized prostate cancer | hiv-1 replication | neuroblastoma cell line | suicide attempts |
| autosomal dominant polycystic kidney disease (adpkd) | colon cancer cell line | hiv-1 reverse transcriptase | neuroblastoma cells | suicide gene |
| avian influenza virus | colon cancer cell lines | hiv-1 strains | neuroblastoma, | suicide ideation |
| avian influenza viruses | colon cancer patients | hiv-1 subtype | neuroendocrine carcinoma | suicide prevention |
| b hepatitis | colon cancers | hiv-1 tat | new cancer | suicide rate |
| b16 melanoma | colon carcinoma cell | hiv-1-infected patients | nicotine addiction | suicide rates |
| bacterial pneumonia | colon carcinoma cells | hiv-2 | (niddm) | suspected coronary artery disease |
| basal cell carcinoma (bcc) | colorectal cancer cell | hiv-infected adults | noncommunicable diseases | sustained virologic response |
| basal-like | colorectal cancer risk | hiv-infected children | non-hiv | syndrome (sars) |
| b-cell lymphoma | colorectal carcinoma | hiv-infected persons | non-hodgkin lymphoma (nhl) | synovial sarcoma |
| bcg vaccination | combination antiretroviral therapy | hiv-infected women | non-hodgkin's lymphoma (nhl) | syphilis |
| birth control | common cancers | hiv-infection | non-insulin-dependent diabetes | t cell lymphoma |
| bladder cancer cell | communicable diseases | hiv-positive individuals | non-insulin-dependent diabetes mellitus | t2dm patients |
| bladder cancer cells | community-acquired pneumonia (cap) | hiv-positive women | nonmelanoma | target for cancer therapy |
| bladder cancers | complication of diabetes | hiv-seropositive | non-melanoma | tb cases |
| bladder carcinoma | congenital heart disease (chd) | hiv-uninfected | non-melanoma skin | tb control |
| bordetella pertussis | congenital heart disease | hodgkin lymphoma (hl) | non-melanoma skin cancer | tb infection |
| bovine tuberculosis | congenital heart diseases | hormonal contraception | nonpolyposis | tb treatment |
| brain cancer | contraceptive method | hormone receptor-positive | nonsmall | testicular cancer |
| breast and ovarian cancer | contraceptive methods | hormone-refractory | nonsmall cell | tetanus toxoid |
| breast cancer cases | coronary heart disease risk | human bladder cancer | nonsmall cell lung | the affordable care act |
| breast cancer chemotherapy | crc cells | human breast cancer cell line | nonsmall cell lung cancer | the cancer genome atlas (tcga) |
| breast cancer detection | crc screening | human breast cancer cell lines | non-small cell lung cancer patients | the influenza virus |
| breast cancer development | creutzfeldt-jakob disease | human breast carcinoma | non-small cell lung cancer | the obesity society |
| breast cancer diagnosis | cutaneous squamous cell carcinoma | human carcinoma | non-small cell lung carcinoma | the risk of breast cancer |
| breast cancer incidence | cutaneous t-cell lymphoma | human cervical cancer | nosocomial pneumonia | therapy for breast cancer |
| breast cancer metastasis | cystic carcinoma | human colon cancer cell | nsclc cell | therapy of cancer |
| breast cancer mortality | cystic fibrosis (cf) patients | human colon cancer cells | nsclc cell lines | thromboembolic pulmonary hypertension |
| breast cancer patient | cystic fibrosis patients | human colon carcinoma | nsclc cells | thyroid cancer |
| breast cancer progression | cystic fibrosis transmembrane conductance regulator (cftr) | human colorectal cancer | obesity and diabetes | thyroid cancers |
| breast cancer resistance | cystic fibrosis | human gastric cancer | obesity and insulin resistance | thyroid carcinoma |
| breast cancer resistance protein | decision aids | human hepatocellular carcinoma (hcc) | obesity and type 2 | tnbc |
| breast cancer subtypes | deep vein thrombosis (dvt) | human immunodeficiency virus infection | obesity and type 2 diabetes | tobacco dependence |
| breast cancer surgery | dengue hemorrhagic | human immunodeficiency virus-1 | obesity epidemic | toxic shock syndrome |
| breast cancer survivors | dengue hemorrhagic fever | human immunodeficiency virus-infected | obesity in children | tract cancer |
| breast cancer susceptibility | dengue infection | human influenza | obesity prevalence | transmembrane conductance regulator (cftr) |
| breast cancer therapy | dengue virus (denv) | human lung cancer cells | obesity prevention | treatment for cancer |
| breast cancer tissue | denv | human malaria | obesity risk | treatment of asthma |
| breast cancer tissues | dependent diabetes | human melanoma cell | obesity treatment | treatment of chronic hepatitis c |
| breast carcinoma cells | dependent diabetes mellitus | human melanoma cells | obesity, diabetes | treatment of colorectal cancer |
| burkitt lymphoma | detection of breast cancer | human neuroblastoma cells | obstetric care | treatment of hepatitis c |
| burkitt's | detection of cancer | human obesity | obstetric complications | treatment of hepatocellular carcinoma |
| burkitt's lymphoma | detection of prostate cancer | human osteosarcoma | obstructive lung disease | treatment of hiv |
| cancer among women | developing breast | human ovarian cancer | occupational asthma | treatment of lung cancer |
| cancer antigen | developing cancer | human pancreatic cancer | oesophageal cancer | treatment of malaria |
| cancer associated | development of asthma | human prostate cancer cell | onset of diabetes | treatment of prostate cancer |
| cancer association | development of breast cancer | human prostate cancer cells | opioid dependence | treatment of tuberculosis |
| cancer biomarker | development of obesity | hypertension and diabetes | oral cancer | triple negative breast |
| cancer biomarkers | diabetes and cardiovascular disease | in cancer tissues | oral contraceptive use | triple negative breast cancer |
| cancer breast | diabetes and hypertension | incidence of cancer | oral squamous cell carcinoma (oscc) | triple-negative breast cancer |
| cancer cachexia | diabetes and obesity | incidence of diabetes | organizing pneumonia | triple-negative breast cancer (tnbc) |
| cancer care | diabetes complications | incidence of stroke | oropharyngeal cancer | tuberculosis (tb) |
| cancer case | diabetes control | individuals with diabetes | osteosarcoma cell | tuberculosis cases |
| cancer cell death | diabetes duration | individuals with type 2 diabetes | osteosarcoma cells | tuberculosis complex |
| cancer cell invasion | diabetes education | inflammation and cancer | osteosarcoma | tuberculosis control |
| cancer cell line | diabetes insipidus | influenza a (h1n1) | ovarian cancer cell line | tuberculosis h37rv |
| cancer cell migration | diabetes insulin | influenza a viruses | ovarian cancer cell lines | tuberculosis patients |
| cancer cell survival | diabetes mellitus (iddm) | influenza b | ovarian cancer patients | tuberculosis strains |
| cancer centers | diabetes mellitus (niddm) | influenza infection | overweight or obesity | tuberculosis treatment |
| cancer centre | diabetes mellitus patients | influenza pandemic | overweight/obesity | type 1 and type 2 diabetes |
| cancer chemoprevention | diabetes mellitus type 2 | influenza season | pancreatic cancer cell | type 1 diabetes (t1d) |
| cancer chemopreventive | diabetes prevention | influenza vaccines | pancreatic cancer cell lines | type 1 diabetes mellitus (t1dm) |
| cancer chemotherapy | diabetes risk | influenza virus infection | pancreatic cancers | type 2 diabetes (t2dm) |
| cancer classification | diabetes self-management | influenzae type b | papillary thyroid cancer | type 2 diabetes mellitus (dm) |
| cancer clinical trials | diabetes status | influenza-like illness | papillary thyroid carcinoma (ptc) | type 2 diabetes patients |
| cancer colorectal | diabetes treatment | insulin resistance obesity | pathogenesis of asthma | type 2 dm |
| cancer data | diabetes type | insulin-dependent diabetes mellitus | pathogenic avian influenza | type i diabetes |
| cancer database | diabetes type 2 | international association for the study of lung cancer | patients with acute stroke | type ii diabetes mellitus |
| cancer detection | diabetes uk | international diabetes federation | patients with advanced cancer | type-2 diabetes |
| cancer development and progression | diabetes; | international prognostic index | patients with aids | undifferentiated carcinoma |
| cancer diagnoses | diabetic kidney disease | interstitial lung disease (ild) | patients with coronary heart disease | urothelial cancer |
| cancer diagnostics | diagnosed diabetes | interstitial lung diseases | patients with esophageal cancer | uterine cancer |
| cancer disease | diagnosis of asthma | invasive bladder | patients with head and neck cancer | uveal melanoma |
| cancer dna | diagnosis of breast cancer | invasive bladder cancer | patients with melanoma | valvular heart disease |
| cancer drugs | diagnosis of cancer | invasive cancer | patients with obesity | ventilator-associated pneumonia (vap) |
| cancer epidemiology | diagnosis of diabetes | invasive cervical cancer | patients with pneumonia | viral hepatitis |
| cancer gastric | diagnosis of hiv | invasive ductal carcinoma | patients with tuberculosis | virologic response |
| cancer gene therapy | diagnosis of lung cancer | ischemic heart disease (ihd) | pediatric asthma | virus hepatitis |
| cancer genes | diagnosis of prostate cancer | ischemic heart disease | pediatric cancer | visceral obesity |
| cancer genetics | diagnosis of tuberculosis | ischemic stroke patients | people living with hiv | vivax malaria |
| cancer hospital | different types of cancer | ischemic strokes | people living with hiv/aids | women with diabetes |
| cancer imaging | differentiated thyroid cancer | japanese encephalitis | perinatal care | yellow fever |
| cancer immunohistochemistry | differentiated thyroid carcinoma | japanese encephalitis virus | perinatal death | zika virus |
| cancer incidence and mortality | diffuse large b cell | kaposi sarcoma | perinatal morbidity | zika virus (zikv) |
| cancer initiation | diffuse large b cell lymphoma | kaposi's sarcoma (ks) | peripheral t-cell lymphoma | zikv |
